Dr Reddy's gains sub-licence to Antara patents
This article was originally published in Scrip
Executive Summary
Dr Reddy's Laboratories, which recently acquired Lupin's US ANDA for fenofibrate capsules, expects to launch the generic in the US prior to the expiry of the patents on Oscient Pharmaceuticals/Ethypharm's cholesterol drug, Antara (fenofibrate) capsules.